HOME >> BIOLOGY >> NEWS
Towards a cheap and easy way to monitor HIV/AIDS

Doctors regularly monitor the level of an immune cell in the blood called a CD4 cell in HIV-infected individuals, to decide when to start treatment and when to change medications. Unfortunately, the existing reliable CD4 counters are large and expensive pieces of equipment, and every actual count is not only expensive but also requires considerable expertise. These tools are therefore unsuitable for many low-income countries.

William Rodriguez and colleagues now report a new way of counting CD4 cells that is cheaper and easier than the current state-of-the-art technology. As they describe in the July issue of the international medical journal PLoS Medicine, their prototype performed well when tested on real-life samples, mostly from adult patients. Its reliability was as good as the existing counters in the range of counts where CD4 numbers are most critical to inform treatment decisions. A fully portable handheld model is now under development. After some modest training, such a tool should allow a variety of health care workers in remote areas to accurately analyze the CD4 status of HIV infected patients locally.

In an accompanying Perspective article, Zvi Bentwich (of Hebrew University in Jerusalem) argues that "the absence of tools to measure CD4 counts clearly jeopardizes the success of recently launched global campaigns to fight AIDS". While acknowledging that several issues remain to be resolved before the assay can become a widely used tool in resource-poor settings, Bentwich states "the authors of this study should be commended for addressing an extremely important issue and developing this novel approach for counting CD4 in patients with HIV."


'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
18-Jul-2005


Page: 1

Related biology news :

1. Dengue and other hemorrhagic fevers: Towards a first potential treatment
2. Towards predicting late-stage radiation toxicity
3. Towards the mechanism of cell respiration
4. Towards a unified model of transcription termination
5. Towards targeted lung cancer treatment
6. New grants bolster efforts to generate faster and cheaper tools for DNA sequencing
7. CESAR could hail cheaper and greener small aircraft
8. The power of one: A simpler, cheaper method for cell fusion
9. Producing flu vaccines will be faster and cheaper, thanks to MSU technology
10. Research milestone brings goal closer of cheap antimalarial drug for developing world
11. Quicker, cheaper DNA sequencing goal of UH profs with $4.2 million NIH grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Towards cheap and easy way monitor HIV AIDS

(Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
(Date:6/23/2015)... 2015   Valencell, a leader in ... a recent study that illustrates its PerformTek biometric ... activity. In a study conducted at Valencell,s Biometric ... the Apple Watch against a chest strap – ... activity. The study demonstrated that Valencell,s biometric technology ...
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... NEW YORK , July 3, 2015  Pomerantz ... filed against Puma Biotechnology, Inc. ("Puma" or the "Company")(NYSE: ... class action, filed in United States District Court, Central ... under 15-cv-00865, is on behalf of a class consisting ... between July 23, 2014 and May 13, 2015 inclusive ...
(Date:7/2/2015)... GLASGOW, Scotland , July 2, 2015 ...   Bio-tech procurement company Amici Procurement has ... IOM) to help it move to Office 365. ... Procurement provides small to medium-sized companies in the ... with all aspects of the purchasing cycle to help ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
Breaking Biology Technology:Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4Biotech Procurement Company Moves to Office 365 with iomart 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3
Cached News: